Report Detail
Global and United States Nephrology Drugs Market Report & Forecast 2022-2028
- RnM4387726 |
- 23 February, 2022 |
- Global |
- 103 Pages |
- QYResearch |
- Medical Industry
Summary:
Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.
Market Analysis and Insights: Global and United States Nephrology Drugs Market
This report focuses on global and United States Nephrology Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Nephrology Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, ACE Inhibitors accounting for % of the Nephrology Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital Pharmacy was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Nephrology Drugs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Nephrology Drugs Scope and Market Size
Nephrology Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Nephrology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Nephrology Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Nephrology Drugs market is segmented into
ACE Inhibitors
Calcium Channel Blocker
Beta Blockers
Diuretics
Others
Segment by Application, the Nephrology Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Nephrology Drugs Market Share Analysis
Nephrology Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Nephrology Drugs business, the date to enter into the Nephrology Drugs market, Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Pfizer
Amgen
FibroGen
GlaxoSmithkline
AbbVie
Akebia Therapeutics
Teva Pharmaceutical Industries
Johnson & Johnson
Roche
Table of Contents
1 Study Coverage
- 1.1 Nephrology Drugs Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million) Introduction
- 1.2 Global Nephrology Drugs Outlook 2017 VS 2022 VS 2028
- 1.2.1 Global Nephrology Drugs Market Size for the Year 2017-2028
- 1.2.2 Global Nephrology Drugs Market Size for the Year 2017-2028
- 1.3 Nephrology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.3.1 The Market Share of United States Nephrology Drugs in Global, 2017 VS 2022 VS 2028
- 1.3.2 The Growth Rate of Nephrology Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
- 1.4 Nephrology Drugs Market Dynamics
- 1.4.1 Nephrology Drugs Industry Trends
- 1.4.2 Nephrology Drugs Market Drivers
- 1.4.3 Nephrology Drugs Market Challenges
- 1.4.4 Nephrology Drugs Market Restraints
- 1.5 Study Objectives
- 1.6 Years Considered
2 Nephrology Drugs by Type
- 2.1 Nephrology Drugs Market Segment by Type
- 2.1.1 ACE Inhibitors
- 2.1.2 Calcium Channel Blocker
- 2.1.3 Beta Blockers
- 2.1.4 Diuretics
- 2.1.5 Others
- 2.2 Global Nephrology Drugs Market Size by Type (2017, 2022 & 2028)
- 2.3 Global Nephrology Drugs Market Size by Type (2017-2028)
- 2.4 United States Nephrology Drugs Market Size by Type (2017, 2022 & 2028)
- 2.5 United States Nephrology Drugs Market Size by Type (2017-2028)
3 Nephrology Drugs by Application
- 3.1 Nephrology Drugs Market Segment by Application
- 3.1.1 Hospital Pharmacy
- 3.1.2 Retail Pharmacy
- 3.1.3 Online Pharmacy
- 3.2 Global Nephrology Drugs Market Size by Application (2017, 2022 & 2028)
- 3.3 Global Nephrology Drugs Market Size by Application (2017-2028)
- 3.4 United States Nephrology Drugs Market Size by Application (2017, 2022 & 2028)
- 3.5 United States Nephrology Drugs Market Size by Application (2017-2028)
4 Global Nephrology Drugs Competitor Landscape by Company
- 4.1 Global Nephrology Drugs Market Size by Company
- 4.1.1 Top Global Nephrology Drugs Companies Ranked by Revenue (2021)
- 4.1.2 Global Nephrology Drugs Revenue by Player (2017-2022)
- 4.2 Global Nephrology Drugs Concentration Ratio (CR)
- 4.2.1 Nephrology Drugs Market Concentration Ratio (CR) (2017-2022)
- 4.2.2 Global Top 5 and Top 10 Largest Companies of Nephrology Drugs in 2021
- 4.2.3 Global Nephrology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.3 Global Nephrology Drugs Headquarters, Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million) Type
- 4.3.1 Global Nephrology Drugs Headquarters and Area Served
- 4.3.2 Global Nephrology Drugs Companies Revenue in Nephrology Drugs Business (2017-2022) & (US$ Million) Type
- 4.3.3 Date of International Companies Enter into Nephrology Drugs Market
- 4.4 Companies Mergers & Acquisitions, Expansion Plans
- 4.5 United States Nephrology Drugs Market Size by Company
- 4.5.1 Top Nephrology Drugs Players in United States, Ranked by Revenue (2021)
- 4.5.2 United States Nephrology Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Nephrology Drugs Market Size by Region
- 5.1 Global Nephrology Drugs Market Size by Region: 2017 VS 2022 VS 2028
- 5.2 Global Nephrology Drugs Market Size by Region (2017-2028)
- 5.2.1 Global Nephrology Drugs Market Size by Region: 2017-2022
- 5.2.2 Global Nephrology Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
- 6.1 North America
- 6.1.1 North America Nephrology Drugs Market Size YoY Growth 2017-2028
- 6.1.2 North America Nephrology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.1.3 United States
- 6.1.4 Canada
- 6.2 Asia-Pacific
- 6.2.1 Asia-Pacific Nephrology Drugs Market Size YoY Growth 2017-2028
- 6.2.2 Asia-Pacific Nephrology Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
- 6.2.3 China
- 6.2.4 Japan
- 6.2.5 South Korea
- 6.2.6 India
- 6.2.7 Australia
- 6.2.8 China Taiwan
- 6.2.9 Indonesia
- 6.2.10 Thailand
- 6.2.11 Malaysia
- 6.3 Europe
- 6.3.1 Europe Nephrology Drugs Market Size YoY Growth 2017-2028
- 6.3.2 Europe Nephrology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.3.3 Germany
- 6.3.4 France
- 6.3.5 U.K.
- 6.3.6 Italy
- 6.3.7 Russia
- 6.4 Latin America
- 6.4.1 Latin America Nephrology Drugs Market Size YoY Growth 2017-2028
- 6.4.2 Latin America Nephrology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.4.3 Mexico
- 6.4.4 Brazil
- 6.4.5 Argentina
- 6.5 Middle East and Africa
- 6.5.1 Middle East and Africa Nephrology Drugs Market Size YoY Growth 2017-2028
- 6.5.2 Middle East and Africa Nephrology Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
- 6.5.3 Turkey
- 6.5.4 Saudi Arabia
- 6.5.5 UAE
7 Company Profiles
- 7.1 AstraZeneca
- 7.1.1 AstraZeneca Company Details
- 7.1.2 AstraZeneca Business Overview
- 7.1.3 AstraZeneca Nephrology Drugs Introduction
- 7.1.4 AstraZeneca Revenue in Nephrology Drugs Business (2017-2022)
- 7.1.5 AstraZeneca Recent Development
- 7.2 Pfizer
- 7.2.1 Pfizer Company Details
- 7.2.2 Pfizer Business Overview
- 7.2.3 Pfizer Nephrology Drugs Introduction
- 7.2.4 Pfizer Revenue in Nephrology Drugs Business (2017-2022)
- 7.2.5 Pfizer Recent Development
- 7.3 Amgen
- 7.3.1 Amgen Company Details
- 7.3.2 Amgen Business Overview
- 7.3.3 Amgen Nephrology Drugs Introduction
- 7.3.4 Amgen Revenue in Nephrology Drugs Business (2017-2022)
- 7.3.5 Amgen Recent Development
- 7.4 FibroGen
- 7.4.1 FibroGen Company Details
- 7.4.2 FibroGen Business Overview
- 7.4.3 FibroGen Nephrology Drugs Introduction
- 7.4.4 FibroGen Revenue in Nephrology Drugs Business (2017-2022)
- 7.4.5 FibroGen Recent Development
- 7.5 GlaxoSmithkline
- 7.5.1 GlaxoSmithkline Company Details
- 7.5.2 GlaxoSmithkline Business Overview
- 7.5.3 GlaxoSmithkline Nephrology Drugs Introduction
- 7.5.4 GlaxoSmithkline Revenue in Nephrology Drugs Business (2017-2022)
- 7.5.5 GlaxoSmithkline Recent Development
- 7.6 AbbVie
- 7.6.1 AbbVie Company Details
- 7.6.2 AbbVie Business Overview
- 7.6.3 AbbVie Nephrology Drugs Introduction
- 7.6.4 AbbVie Revenue in Nephrology Drugs Business (2017-2022)
- 7.6.5 AbbVie Recent Development
- 7.7 Akebia Therapeutics
- 7.7.1 Akebia Therapeutics Company Details
- 7.7.2 Akebia Therapeutics Business Overview
- 7.7.3 Akebia Therapeutics Nephrology Drugs Introduction
- 7.7.4 Akebia Therapeutics Revenue in Nephrology Drugs Business (2017-2022)
- 7.7.5 Akebia Therapeutics Recent Development
- 7.8 Teva Pharmaceutical Industries
- 7.8.1 Teva Pharmaceutical Industries Company Details
- 7.8.2 Teva Pharmaceutical Industries Business Overview
- 7.8.3 Teva Pharmaceutical Industries Nephrology Drugs Introduction
- 7.8.4 Teva Pharmaceutical Industries Revenue in Nephrology Drugs Business (2017-2022)
- 7.8.5 Teva Pharmaceutical Industries Recent Development
- 7.9 Johnson & Johnson
- 7.9.1 Johnson & Johnson Company Details
- 7.9.2 Johnson & Johnson Business Overview
- 7.9.3 Johnson & Johnson Nephrology Drugs Introduction
- 7.9.4 Johnson & Johnson Revenue in Nephrology Drugs Business (2017-2022)
- 7.9.5 Johnson & Johnson Recent Development
- 7.10 Roche
- 7.10.1 Roche Company Details
- 7.10.2 Roche Business Overview
- 7.10.3 Roche Nephrology Drugs Introduction
- 7.10.4 Roche Revenue in Nephrology Drugs Business (2017-2022)
- 7.10.5 Roche Recent Development
8 Research Findings and Conclusion
9 Appendix
- 9.1 Research Methodology
- 9.1.1 Methodology/Research Approach
- 9.1.2 Data Source
- 9.2 Author Details
Summary:
Get latest Market Research Reports on Nephrology Drugs. Industry analysis & Market Report on Nephrology Drugs is a syndicated market report, published as Global and United States Nephrology Drugs Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Nephrology Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
